EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Steensrud, T.
Right arrow Articles by Sørlie, D.G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Steensrud, T.
Right arrow Articles by Sørlie, D.G.
Related Collections
Right arrow Myocardial protection

Eur J Cardiothorac Surg 2003;23:670-677
© 2003 Elsevier Science NL


Superior myocardial protection with nicorandil cardioplegia

T. Steensrud*, D. Nordhaug, O.P. Elvenes, C. Korvald, D.G. Sørlie

Department of Cardiothoracic and Vascular Surgery, University Hospital of North Norway, Breivika, P.O. Box 102, N-9038 Tromsø, Norway

Received 30 September 2002; received in revised form 20 January 2003; accepted 23 January 2003.

* Corresponding author. Tel.: +47-77-626-000/637-338; fax: +47-77-628-298
e-mail: tors{at}fagmed.uit.no

Objective: The ATP-sensitive potassium channel (KATP) activator nicorandil used as cardioplegic agent may protect the left ventricle during cardiac arrest. Nicorandil in cold blood was compared with standard hyperkalemic blood and crystalloid cardioplegia. Methods: Twenty-one pigs were randomly assigned to three groups: (1) cold hyperkalemic crystalloid (n=7); (2) cold hyperkalemic blood (n=7); and (3) nicorandil as cardioplegia in cold blood (n=7). Left ventricular mechanical performance, pressure-volume area (PVA) and myocardial oxygen consumption (MVO2) were measured before and at 1 and at 2 h after 60 min of cold global ischemia on cardiopulmonary bypass using intraventricular pressure-volume conductance catheters, coronary flow probes and O2-content difference. Results: The slope (Mw) of the stroke work end-diastolic volume relationship, the preload recriutable stroke work relationship, was unchanged after ischemia in the nicorandil group, but was reduced to averaged 62.5% (standard deviation 14) of baseline values in both hyperkalemic perfusions (P<0.05). The slope of the MVO2-PVA relationship was unchanged after nicorandil cardioplegia while the slope after hyperkalemic blood and crystalloid cardioplegia increased with 33% (P<0.02) and 52% (P<0.02) of baseline values, respectively. Conclusions: Nicorandil as sole cardioplegic agent in cold blood given intermittently preserves left ventricular contractility and myocardial energetics significantly better than traditional forms of cardioplegia after cardiac arrest.

Key Words: Cardioplegia • Energetics • Myocardial protection • Nicorandil




This article has been cited by other articles:


Home page
ICVTSHome page
T. Steensrud, S. Muller, P. C. Endresen, and D. G. Sorlie
Clinical testing of nicorandil supplemented normokalemic cardioplegic solution
Interactive CardioVascular and Thoracic Surgery, October 1, 2006; 5(5): 521 - 525.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
T. Steensrud, O. Jakobsen, K. Ytrehus, and D. G. Sorlie
Contractile recovery of heart muscle after hypothermic hypoxia is improved by nicorandil via mitochondrial K(ATP) channels.
Eur. J. Cardiothorac. Surg., August 1, 2006; 30(2): 256 - 262.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
Y.-Y. Dong, M. Wu, A. P.C. Yim, and G.-W. He
Hypoxia-Reoxygenation, St. Thomas Cardioplegic Solution, and Nicorandil on Endothelium-derived Hyperpolarizing Factor in Coronary Microarteries
Ann. Thorac. Surg., November 1, 2005; 80(5): 1803 - 1811.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
Q. Yang, R.-Z. Zhang, A. P.C. Yim, and G.-W. He
Release of Nitric Oxide and Endothelium-Derived Hyperpolarizing Factor (EDHF) in Porcine Coronary Arteries Exposed to Hyperkalemia: Effect of Nicorandil
Ann. Thorac. Surg., June 1, 2005; 79(6): 2065 - 2071.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
O.-J. How, E. Aasum, S. Kunnathu, D. L. Severson, E. S. P. Myhre, and T. S. Larsen
Influence of substrate supply on cardiac efficiency, as measured by pressure-volume analysis in ex vivo mouse hearts
Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2979 - H2985.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. Lin, Z.-W. Zhang, Q.-X. Xiong, C.-M. Cao, Q. Shu, I. C. Bruce, and Q. Xia
Pinacidil improves contractile function and intracellular calcium handling in isolated cardiac myocytes exposed to simulated cardioplegic arrest
Ann. Thorac. Surg., September 1, 2004; 78(3): 970 - 975.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
D. J. Chambers
Nicorandil cardioplegia or procaine cardioplegia?
Eur. J. Cardiothorac. Surg., October 1, 2003; 24(4): 670 - 670.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2003 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.